7月31日电，CVS健康公司美股盘前涨超4%。此前，公司上调2024财年调整后每股收益指引至6.30-6.40美元，原预期为6.00-6.20美元，市场预估6.13美元。

Core Viewpoint - CVS Health Company shares rose over 6% in pre-market trading following the upward revision of its fiscal year 2024 adjusted earnings per share guidance to $6.30-$6.40, compared to the previous expectation of $6.00-$6.20, while market estimates were at $6.13 [1] Summary by Category - Earnings Guidance - CVS Health has increased its adjusted earnings per share guidance for fiscal year 2024 to a range of $6.30 to $6.40 [1] - The previous guidance was set between $6.00 and $6.20 [1] - Market expectations were at $6.13 [1]